ISpecimen Correlations

ISPC Stock

USD 0.24 0.04 14.29%

The current 90-days correlation between iSpecimen and ENDRA Life Sciences is 0.23 (i.e., Modest diversification). The correlation of ISpecimen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

ISpecimen Correlation With Market

Pay attention - limited upside

The correlation between iSpecimen and DJI is -0.73 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding iSpecimen and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with ISpecimen Stock

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iSpecimen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For information on how to trade ISpecimen Stock refer to our How to Trade ISpecimen Stock guide.

Moving together with ISpecimen Stock

0.72	DRMA	Dermata Therapeutics	Pair Corr
0.83	DTIL	Precision BioSciences	Pair Corr

Moving against ISpecimen Stock

0.75	EQ	Equillium	Pair Corr
0.71	GXEA	Galapagos NV	Pair Corr
0.52	VALN	Valneva SE ADR	Pair Corr
0.47	8VP1	AVRICORE HEALTH INC	Pair Corr
0.72	0P6S	Bayer AG NA	Pair Corr
0.71	DRTS	Alpha Tau Medical	Pair Corr
0.55	6C1	CytomX Therapeutics	Pair Corr
0.55	DSGN	Design Therapeutics	Pair Corr
0.51	DRUG	Bright Minds Biosciences	Pair Corr
0.5	VERA	Vera Therapeutics	Pair Corr
0.36	SAB	Sonic Healthcare	Pair Corr
0.7	VNDA	Vanda Pharmaceuticals	Pair Corr
0.57	DVAX	Dynavax Technologies	Pair Corr
0.57	HDP1	Arrowhead Pharmaceuticals	Pair Corr
0.51	ALA	Arovella Therapeutics Earnings Call Tomorrow	Pair Corr
0.5	SRZNW	Surrozen Warrant	Pair Corr

Related Correlations Analysis

	NDRA	TOVX	VTAK	HSCS	GLMD	BJDX	BIVI	BIAF	SHPH	ZCMD
NDRA		0.59	0.44	-0.45	0.86	0.75	0.76	0.78	0.27	0.82	NDRA
TOVX	0.59		0.3	-0.13	0.55	0.57	0.49	0.55	0.11	0.53	TOVX
VTAK	0.44	0.3		-0.16	0.7	0.31	0.62	0.63	0.34	0.5	VTAK
HSCS	-0.45	-0.13	-0.16		-0.41	-0.43	-0.63	-0.29	0.31	-0.39	HSCS
GLMD	0.86	0.55	0.7	-0.41		0.66	0.82	0.87	0.38	0.84	GLMD
BJDX	0.75	0.57	0.31	-0.43	0.66		0.62	0.65	0.12	0.61	BJDX
BIVI	0.76	0.49	0.62	-0.63	0.82	0.62		0.79	0.02	0.65	BIVI
BIAF	0.78	0.55	0.63	-0.29	0.87	0.65	0.79		0.27	0.79	BIAF
SHPH	0.27	0.11	0.34	0.31	0.38	0.12	0.02	0.27		0.42	SHPH
ZCMD	0.82	0.53	0.5	-0.39	0.84	0.61	0.65	0.79	0.42		ZCMD
	NDRA	TOVX	VTAK	HSCS	GLMD	BJDX	BIVI	BIAF	SHPH	ZCMD

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BIAF	+ 0.87	GLMD
GLMD	+ 0.86	NDRA
ZCMD	+ 0.84	GLMD
ZCMD	+ 0.82	NDRA
BIVI	+ 0.82	GLMD
BIAF	+ 0.79	BIVI

High negative correlations

BIVI	- 0.63	HSCS
HSCS	- 0.45	NDRA
BJDX	- 0.43	HSCS
GLMD	- 0.41	HSCS
ZCMD	- 0.39	HSCS
BIAF	- 0.29	HSCS

Risk-Adjusted Indicators

There is a big difference between ISpecimen Stock performing well and ISpecimen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ISpecimen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NDRA	4.53	(0.64)	0.00	(0.47)	0.00	0.00	10.23	(8.88)	31.66
TOVX	5.58	(0.35)	0.00	(0.06)	0.00	0.00	10.53	(13.64)	38.10
VTAK	5.63	(0.05)	0.01	0.05	7.37	(6.80)	13.33	(10.00)	57.11
HSCS	4.09	0.11	0.00	(0.23)	4.97	(4.92)	11.07	(7.86)	21.61
GLMD	4.23	(0.92)	0.00	(0.69)	0.00	0.00	9.33	(8.96)	21.39
BJDX	4.41	(1.59)	0.00	(0.60)	0.00	0.00	8.08	(9.60)	46.34
BIVI	3.34	(0.21)	0.00	(0.05)	0.00	0.00	8.16	(7.30)	23.28
BIAF	5.05	(0.81)	0.00	(0.16)	0.00	0.00	11.40	(12.79)	32.32
SHPH	7.32	(0.31)	0.00	0.19	0.00	0.00	15.69	(14.37)	55.61
ZCMD	5.63	(1.25)	0.00	(0.37)	0.00	0.00	10.42	(13.33)	69.77

ISpecimen Corporate Management

Emily Hubbard	VP Devel	Profile
Benjamin Bielak	Chief Secretary	Profile
Eric Langlois	Chief Officer	Profile
Dawn Michelle	VP Operations	Profile
Yuying Liang	Chief Officer	Profile
Annette Arnold	Vice Development	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC